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aortic balloon pump.4 In 1 animal, an SMV lined with
autogenous pericardium functioned continuously for
over 4 years in circulation.
In acute studies, the most effective configuration for
skeletal muscle hemodynamic assist that we have tested
has been an SMV attached from the left ventricular (LV)
apex to the aorta.5 In a recent study6 with this configura-
tion, the longest survival we obtained was 11 weeks in 1
animal, with the others surviving only 10 to 14 days.
Because the addition of a pericardial lining to the inner
layer of the SMV was important in establishing the aor-
tic counterpulsator model as a reproducible chronic
model, the SMVs in our study were lined with autoge-
nous pericardium. The purpose of this study was to
develop pericardium-lined SMVs in a LV apex–to–aorta
configuration as a chronic model for cardiac assist and
to document hemodynamic performance over time.
Materials and methods
SMV construction and conditioning. Pericardium-lined
SMVs were constructed in 10 mongrel dogs, weighing
between 16 and 22 kg, by a technique that has previously been
W e have studied thc use of skeletal muscle for car-diac assist by constructing muscular pouches,
which we term skeletal muscle ventricles (SMVs).
These SMVs have been connected to the circulation in
a variety of ways for both left and right heart assist.1-3
When they were attached directly to the descending
thoracic aorta and stimulated as aortic counterpulsators,
we demonstrated that SMVs can pump blood chronically
in the circulation, providing effective augmentation of
diastolic blood pressure in a manner similar to the intra-
Objective: The purpose of this experiment was to evaluate the potential for
a skeletal muscle ventricle connected to the circulation between the left
ventricle and the aorta to provide effective, long-term cardiac assist.
Methods: Skeletal muscle ventricles were constructed from the latissimus
muscle in 10 dogs. After conditioning, the skeletal muscle ventricles were
connected to the left ventricle and the aorta with 2 valved conduits. The
skeletal muscle ventricle was programmed to contract during diastole.
Results: At time of implantation, skeletal muscle ventricles stimulated at
33 Hz and in a 1:2 ratio with the heart significantly decreased left ven-
tricular work by 56% (P < .01) and at 50 Hz by 65% (P < .01). At a 1:2
ratio, the power output of the skeletal muscle ventricles was 59% of left
ventricular power output at 33 Hz (P < .01) and 93% at 50 Hz (P < .01).
Animals survived 7, 11, 16, 17, 72, 99, 115, 214, and 249 days. Three
deaths were directly related to the skeletal muscle ventricle. One animal
is alive at 228 days. In the animal that survived 249 days, skeletal muscle
ventricle power output at 8 months with a 33 Hz stimulation frequency
and a 1:2 contraction ratio was 57% of left ventricular power output and
82% at 50 Hz. At a 1:1 ratio, skeletal muscle ventricle power output was
97% and 173% of the left ventricle at 33 and 50 Hz, respectively.
Conclusions: Left ventricular assist with a skeletal muscle ventricle con-
nected between the left ventricle and the aorta is the most hemodynami-
cally effective configuration we have tested and can maintain significant
power output up to 8 months. (J Thorac Cardiovasc Surg 1998;116:1029-42)
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described.7 All animals underwent operation in accordance
with the “Guide for the Care and Use of Laboratory Animals”
published by the National Institutes of Health (NIH publica-
tion 85-23, revised 1985).
In brief, after induction of inhalational anesthesia, the peri-
cardium was harvested from between the phrenic nerves
through a right thoracotomy incision. At this time, a transit-
time ultrasonic flow probe (A-Series; Transonic Systems, Inc,
Ithaca, NY) was placed around the ascending aorta to measure
blood flow at that point. The connecting portion of the probe
was tunnelled to the mid-dorsal subcutaneous tissue. Next, the
left latissimus dorsi muscle was mobilized from the chest wall
through a separate flank incision, leaving its humeral insertion
intact. A bipolar nerve lead (Medtronic, Inc, Minneapolis,
Minn) was placed around the thoracodorsal nerve. The lead
was connected to a neurostimulator (Itrel model 7421;
Medtronic, Inc), which was placed in the left rectus sheath.
The autogenous, fresh pericardium was wrapped around a
cylindrical polypropylene mandrel (diameter 3.4 cm, volume
2.5 mL/kg) and secured at the base with 5-0 polypropylene
suture to a ring of Dacron felt (USCI, Billerica, Mass). The
latissimus muscle was then wrapped circumferentially around
the pericardium-lined mandrel from 1.5 to 2 times. The mus-
cle was secured to the sewing ring with polypropylene sutures,
and the SMV layers were tacked together with superficially
placed polyglactin acid sutures. The wounds were closed in
layers with absorbable polyglactin acid sutures.
All animals underwent a 3-week period of vascular delay
from the time of SMV construction before conditioning. The
neurostimulator was then activated to deliver a 2-Hz single
pulse of 1- to 1.5-volt amplitude and 210-m s duration for a
period of 6 weeks. This has been shown to induce transfor-
mation of the muscle fiber histologic condition from fast-
twitch, fatiguable to slow-twitch, fatigue-resistant fibers.8
Connection to the circulation. The configuration of the
SMV in relation to its connection to the circulation and the
sites of pressure and flow sensors are depicted in Fig 1.
After the conditioning process was complete, the dogs were
reanesthetized and the SMV mandrel was removed. The left
side of the chest was entered through the fourth intercostal
space. A specially constructed valved conduit consisting of
a combination of a ringed polytetrafluoroethylene graft* (12
mm) with an interposed porcine valved Dacron conduit (12
mm, Hancock; Medtronic, Inc) was anastomosed end to
side to the descending thoracic aorta. The proximal portion
of this conduit was connected to a base-cap of polytetraflu-
oroethylene cardiovascular patch, which was anastomosed
to the SMV. A 10-mm ventriculotome was then used to
excise a cylindrical portion of the LV apex. A second spe-
cially constructed 12-mm valved conduit, also connected to
the SMV base cap, was then anastomosed without car-
diopulmonary bypass to the ventricular apex with a right-
1030 Thomas et al The Journal of Thoracic and
Cardiovascular Surgery
December 1998
*Gore-Tex graft, registered trade name of WL Gore & Associates,
Inc, Flagstaff, Ariz.
Fig 1. SMV is connected to the circulation between the LV apex and descending aorta with 2 valved conduits. A
constriction was created proximal to the SMV-aortic anastomosis. Pressure was monitored in the left ventricle,
SMV, and femoral and carotid arteries. Flow was measured at the aortic root and in the SMV efferent conduit.
angled plastic connector (Medtronic, Inc). The connector
was secured to the ventricular apex with interrupted, 2-0
pledget-supported polyester sutures. An epicardial sensing
electrode (model 6917; Medtronic, Inc) was attached on the
left ventricle. The grafts were de-aired, and the nerve stimu-
lator was replaced with a synchronized pulse-train cardio-
myostimulator (SP1005; Medtronic, Inc). The stimulator was
programmed to deliver a 33-Hz burst train stimulus (each
pulse of 210 m s duration), with a delay of 225 to 250 ms from
the R wave and a burst train duration of 240 ms. The descend-
ing thoracic aorta just distal to the left subclavian artery, but
proximal to the aortic anastomosis, was then narrowed
approximately 50% with umbilical tape to increase passive
flow from the left ventricle through the SMV circuit during
cardiac systole. After partial aortic ligation, total cardiac out-
put and LV pressure remained the same; but passive flow
through the SMV, which had been minimal, increased to 15%
to 35% of the total systemic output.
No attempt was made to prevent thrombosis with heparin
or warfarin. The dogs were given 85 mg of aspirin orally
every day as their only anticoagulant.
Hemodynamic measurements. Initial hemodynamic mea-
surements were made after the SMV was connected to the
circulation. In addition to the aortic flow probe that was
placed at the time of SMV construction, a second ultrasonic
flow probe was placed around the efferent conduit from the
SMV. Polyurethane catheters (2.5F) were inserted into the
left ventricle, the SMV, and the carotid artery and connected
to implantable subcutaneous ports (Vascular-Access Ports;
Vascular Access Technologies, Skokie, Ill). They were used
for pressure monitoring with fluid-filled tubing connected to
transducers. A temporary cannula for pressure monitoring
was placed in the femoral artery. Measurements were made
not only with the stimulator OFF and ON at the chronic set-
ting of 33 Hz, mode 2, but also at 33-Hz and 50-Hz burst
stimulation with the cardiomyostimulator set at both mode 1
(heart rate to SMV ratio l:l when heart rate is less than 120
beats/min; 1:2 when greater than 120 beats/min) and mode 2
(ratio 1:2, heart rate less than 120 beats/min; 1:3 when greater
than 120 beats/min). The varying burst frequencies and con-
traction ratios were tested to show the potential for skeletal
muscle to provide increased assistance at these more intense
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Fig 2A. Pressure recordings made at the time of connection of the SMV to the systemic circulation. Transition
from the control state with the SMV OFF to stimulation at 33 Hz, 1:2, can be seen, with corresponding changes
in the flow and pressure tracings. 
stimulation parameters. Data were collected as hardcopy on a
Gould ES 1000B recording and display system (Gould
Instruments Systems, Valleyview, Ohio) and digitally on a
computer utilizing a data acquisition and analysis program
(Windaq; Dataq Instruments, Akron, Ohio). The sampling
rate was 400 Hz. The incision was then closed in layers, and
the flow probes and 3 pressure monitoring ports were left
near the mid-dorsal area of the animals’ subcutaneous tissue.
The cardiomyostimulator was placed beneath the rectus
sheath. The stimulator was set chronically to contract in mode
2, with a 225- to 250-ms delay and 240-ms duration at 33-Hz
burst frequency.
Chronic hemodynamic measurements. The animals were
allowed to recover after the SMVs were placed in circulation.
The pressure monitoring ports were flushed 2 to 3 times
weekly to maintain patency with a 500-unit/mL concentration
of sodium heparin. Hemodynamic measurements on each
animal were then performed at 1 and 2 weeks and 1, 2, and 3
months and roughly every 2 to 3 months thereafter, unless a
change in the animal’s condition occurred. During a subse-
quent pressure recording at 2 to 3 months in 4 of the animals,
a continuous infusion of intravenous propranolol was given at
1 mg/kg per minute for 1 hour after a 10-mg/kg bolus dose to
induce a low cardiac output state, defined as a decrease in
aortic blood flow of 50% from control. In 1 dog the infusion
was discontinued because of a sudden, precipitous fall in
blood pressure. In the remaining 3 dogs, data under low out-
put conditions were recorded after 1 hour of continuous pro-
pranolol infusion.
Data analysis. Hemodynamic recordings were analyzed
on a computer using the data acquisition and analysis pro-
gram (Windaq; Dataq Instruments, Inc). Data were analyzed
for each setting for a minimum of 10 SMV beats (total heart-
beats 10 to 30, depending on contraction ratio).
Stroke volumes for both the SMV and the left ventricle
were determined by integrating the area underneath the SMV
and aortic flow traces. SMV stroke volume was defined as the
stroke volume only during SMV ejection (Fig 2B). To calcu-
late the work done by the left ventricle pumping blood
through the SMV circuit versus work done by the SMV itself,
the flow through the SMV when the SMV was contracting
was divided into active and passive components. Passive
SMV flow was defined as all the flow through the SMV dur-
ing the cardiac cycle except for SMV ejection. This definition
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Fig 2B. The SMV is seen contracting at 33 Hz at a 1:2 ratio (the chronic stimulation setting) with the heart; shaded
areas in the SMV flow trace indicate SMV stroke volume.
of passive SMV flow assumes that passive flow is indepen-
dent of SMV relaxation and likely underestimates the contri-
bution that SMV relaxation adds to the flow through SMV
circuit and ascribes it to the left ventricle instead. LV stroke
volume was defined as the sum of flow across the aortic valve
plus passive SMV flow for a cardiac cycle.
The LV and SMV tension time indices were calculated by
integrating the pressure measurements collected from within
each respective ventricle (cardiac or skeletal muscle) during
their respective systolic contractions. Stroke work was
defined for both the left ventricle and the SMV as the prod-
uct of the ejected stroke volume (including passive flow
through the SMV as part of LV stroke volume) and the mean
pressure in the ventricle during its systole. Power output was
calculated as the product of stroke work and the number of
contractions per minute of the respective ventricle. Data are
expressed as mean ± SD. Statistical analysis was performed
with SPSS for Windows (SPSS Inc, Chicago, Ill), with an
analysis of variance for repeated measures with a Helmert
contrast to test for differences for the hemodynamic parame-
ters between the SMV OFF state and during stimulation at
33 Hz and 50 Hz and between 33-Hz and 50-Hz stimulation.
Results
Initial hemodynamic data. Data obtained at time of
connection of the SMV to the circulation are presented
in Tables I and II. The decrease in LV end-diastolic
pressure with the pacemaker ON versus OFF, although
statistically significant, was only 0.7 mm Hg at 33 Hz
and 1.2 mm Hg at 50 Hz. At the chronic stimulation
frequency of 33 Hz, 1:2 contraction ratio with the heart,
LV peak systolic pressure decreased in the beat follow-
ing SMV contraction by 19% at 33 Hz and by 22% at
50 Hz. Diastolic blood pressure measured in the SMV
during SMV contraction was augmented 36% when
compared with the mean diastolic blood pressure with
the SMV OFF. At 50 Hz burst frequency, 1:2 ratio, the
diastolic augmentation was 50%. During SMV relax-
ation, the diastolic pressure in the SMV decreased by
60% when compared with the diastolic pressure on
unstimulated beats.
During SMV-cardiac assistance at a 1:2 ratio, a sig-
nificant portion of the flow through the left ventricle
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Fig 2C. Pressure recording made after 248 days of pumping blood continuously in the circulation. The SMV is
shown contracting at 50 Hz, 1:1 ratio. 
was diverted from the native LV outflow tract and
rerouted through the SMV. During the initial hemody-
namic recordings in all 10 animals, passive SMV flow
(the amount of flow being pumped by the left ventricle
through the SMV circuit) averaged 26% of the total
blood flow. During SMV contraction at 33 Hz, 1:2
ratio, the blood flow through the SMV increased such
that 40% of the total systemic flow was directed
through the SMV. At a burst frequency of 50 Hz, 43%
of the total systemic flow went through the SMV. The
measured stroke volume through the aortic valve after
an SMV contraction decreased 40% and 45% at 33 and
50 Hz, respectively. However, because of the increase
in blood flow through the SMV, total systemic blood
flow essentially remained the same.
The initial hemodynamic data also showed significant
reductions in the LV tension time index and LV stroke
work (LVSW) and minute work (LVMW) during SMV
contractions. The LV tension time index decreased by
29% at 33 Hz and 39% at 50 Hz. At 33 Hz, LVSW
1034 Thomas et al The Journal of Thoracic and
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Table I. Initial measured hemodynamic data averaged for all 10 dogs
OFF ON at 33 Hz ON at 50 Hz
OFF vs ON 33 Hz vs 50 Hz 
Mean SD Mean SD Mean SD (P value) (P value)
Heart rate 132 13 133 16 135 15 NS NS
mFAP 67.1 8.9 66.1 9.0 63.5 15.0 NS NS
mCarotid 72.7 6.2 72.1 8.4 72.7 7.4 NS NS
LVEDP 13.1 5.2 12.4 5.1 11.9 5.4 .012 NS
LVSys 90.9 9.9 74.1 15.9 71.3 14.2 <.01 NS
Peak SMVP * * 81.5 17.1 89.5 19.9 * NS
SMV Dia 59.8 7.9 24.5 16.4 25.6 12.2 <.01 NS
mAoQ 2427 534 1847 515 1744 486 <.01 .027
mSMVQ 648 294 1218 409 1316 528 <.01 NS
Total Q 3075 631 3065 490 3060 474 NS NS
LVSVAo 20.0 6.0 12.0 5.0 11.0 4.9 <.01 NS
Passive SMVSV 5.2 2.0 2.8 1.5 1.9 1.1 <.01 <.01
SMVSV * * 10.3 4.2 13.6 4.9 * <.01
mFAP, Mean femoral artery pressure; mCarotid, mean carotid artery pressure; LVEDP, LV end-diastolic pressure; LVSys, peak LV systolic pressure; peak SMVP,
peak pressure during SMV contraction; SMV Dia, diastolic pressure inside the SMV; mAoQ, mean flow across the ascending aorta; mSMVQ, mean flow through the
SMV; total Q, sum of mAoQ + SMVQ; LVSVAo, portion of left ventricular stroke volume ejected through the aortic valve; Passive SMVSV, portion of stroke volume
through the SMV caused by LV ejection; SMVSV, stroke volume from the SMV during SMV contraction.
*Data not obtainable.
P values were determined with analysis of variance.
Table II. Initial derived hemodynamic parameters averaged from all 10 dogs
OFF ON at 33 Hz ON at 50 Hz
OFF vs ON 33 Hz vs 50 Hz 
Mean SD Mean SD Mean SD (P value) (P value)
LVTTI 14 3 10 4 9 4 <.01 NS
SMV TTI * * 18 4 25 9 * <.01
LVSW 1601 694 707 535 558 476 <.01 <.01
LVSWI 2319 959 1026 771 811 691 <.01 <.01
SMV SW * * 816 479 1517 946 * <.01
SMV SWI * * 1191 677 2207 1355 * <.01
LVMW 205611 73040 92060 66539 74011 61284 <.01 <.01
LMWI 299090 102355 134249 97572 107989 902212 <.01 <.01
SMV MW * * 53865 31008 100377 61530 * <.01
SMV * * 79039 45447 147064 92572 * <.01
LVTTI, LV tension time index; SMV TTI, SMV tension time index; LVSWI, LV stroke work index; SMV SWI, SMV stroke work index; LVMWI, LV minute work
index; SMVMW, SMV minute work (power output); SMVMWI, SMV minute work index.
*Data not obtainable. 
P values determined by analysis of variance. 
decreased by 56% when compared with the LVSW with
the cardiomyostimulator OFF. LVSW was decreased by
65% when the SMV was stimulated at 50 Hz. LV power
output (LVMW) was decreased by 55% at 33 Hz and
64% at 50 Hz. The SMV itself, when stimulated at 33
Hz, was capable of 51% of the stroke work of the native
left ventricle alone with the SMV OFF and 95% of
native (unassisted) LVSW at 50-Hz burst stimulation.
When SMV stroke work (SMV SW) was compared
with the assisted LVSW, SMV SW exceeded that of the
assisted left ventricle: at 33 Hz, SMV SW was 115% of
LVSW and 271% of LVSW at 50 Hz. At the chronic
stimulation setting of 33 HZ and a 1:2 ratio, SMV
power output (SMVMW) was 26% of thc native left
ventricle and 59% of the assisted LVMW. At the higher
burst stimulation frequency of 50 Hz, the SMV power
output was 49% of the native LV power output and
136% of the assisted power output of the left ventricle.
Chronic SMV function. The SMVs were assessed
over time. Fig 3 depicts both the active flow through
the SMV circuit (total flow through SMV during stim-
ulation) and the passive flow (total flow with SMV
OFF) through the SMV for the 6 animals that survived
1 month and beyond, for the duration of the experi-
ment. The data on the additional 4 dogs were similar;
they were excluded only for clarity of the illustration.
There is an initial drop in SMV performance, as mea-
sured by SMV flow, that is seen in the 1-week mea-
surement after the initial connection to the circulation.
However, during subsequent measurements, the flow
through the SMV approaches the value obtained at the
time of connection to the circulation. Once returning
towards baseline, the function of the SMVs remained
relatively stable over time in most dogs.
Four dogs were studied under conditions of pharma-
cologically induced acute cardiac failure at 2 to 3
months in circulation. In 1 of these dogs, infusion of
propranolol resulted in rapid and profound hemody-
namic collapse; although the animal was allowed to
recover, these data were excluded from the analysis. In
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Fig 3. Blood flow through the SMV circuit at 33 Hz, 1:2 (combined SMV stroke volume plus passive stroke vol-
ume), versus passive flow with the SMV OFF for each of the 6 dogs that survived more than 1 month is shown
for the duration of the experiment. SMV blood flow is expressed as percent of total systemic blood flow. 
the 3 remaining dogs, cardiac output was decreased by
50% of control for 1 hour, and SMV performance was
assessed before and after propranolol infusion (Fig 4).
During heart failure, there was no statistical difference
in the percentage of total blood flow through the SMV
circuit before propranolol infusion when compared
with that during propanolol infusion. The percentage of
total systemic output flowing through the SMV fell
minimally at 33 Hz, 1:2; however, it showed a definite
trend toward increasing under failure conditions at 50
Hz, 1:2, and both 33 and 50 Hz at a 1:1 contraction
ratio. When expressed as a percentage of native LV
work or power, neither stroke work or power output of
the SMV changed significantly between the control and
heart failure states. Pressure tracings from 1 animal
before and after induction of a low-output state at dif-
ferent contraction ratios are shown in Fig 5.
The fate of each of the 10 dogs with LV apex–to–aorta
configured SMVs is shown in Table III. One dog was
alive 228 days (as of July 7, 1998); the remaining dogs
survived 7 to 249 days with SMVs pumping blood in
circulation. Of the dogs that died, 6 deaths, including
the initial 4 dogs, were for reasons not directly related to
the function of the SMV in the circulation. Technical
factors in placing the SMVs in circulation or during
subsequent measurements were directly related to the
deaths of these first 4 animals. This likely represents a
learning curve for the development of this model. One
dog died of unexplained spontaneous retroperitoneal
bleeding, and 1 dog died of an infection at the car-
diomyostimulator site. Three dogs died of thromboem-
bolic complications, presumably from the SMV.
However, presence of thrombus in the SMV was detected
in only 1 dog.
One animal in this series survived 8 months in circu-
lation. Pressure and flow traces from implantation and
at day 248 are presented in Fig 2. The flow and pres-
sure traces were similar throughout the time that this
animal’s SMV was in circulation. The distribution of
total blood flow compared between stimulator OFF and
ON at 33 Hz, 1:2 (chronic setting), is depicted in Fig 6.
Initially, flow through the SMV with the stimulator at
33 Hz, 1:2, was greater than flow through the native LV
outflow tract. At the interval 2-week recording, there
was a substantial dip in SMV flow that stabilized at the
3-month recording; from that time, the flow through
the SMV and through the aortic valve each comprised
approximately one half of the total systemic output.
Fig 7 depicts the stroke work of the SMV and left
ventricle over time for this animal. SMV SW at 33 Hz
was about equal to that of the native left ventricle (with
the stimulator OFF). SMV SW was about 1.5 to 3 times
that of the assisted left ventricle throughout the study,
with the exception of the measurement at 8 months. At
50 Hz, the stroke work of the SMV decreased below
that of the native left ventricle at 2 weeks but otherwise
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Fig 4. SMV blood flow, expressed as percentage of total systemic flow, at varying burst frequencies and con-
traction ratios before induction of heart failure with propranolol (control; solid bars) and after inducing failure
with propranolol (heart failure; shaded bars).
remained superior to that of the native left ventricle.
Stroke work at 50 Hz remained 2 to 3 times that of the
assisted ventricle. Under both burst frequencies, LVSW
decreased dramatically with the SMV ON compared
with the SMV OFF.
Power output of the left ventricle and SMV was also
calculated over time for the longest surviving animal at
both 33 and 50 Hz, for 1:2 and 1:1 assist ratios (Fig 8).
Power output of the SMV at 33 Hz, 1:2, was compara-
ble to the assisted left ventricle. It remained stable from
3 to 8 months after the SMV was placed into circula-
tion. Power output at 50 Hz, 1:2, was also comparable
to that of the assisted ventricle and remained relatively
stable throughout the study period. At a l:l ratio with
the heart, SMV power exceeded that of the native,
unassisted left ventricle by 42% at 33 Hz and 29% at
50 Hz. Over time, the SMV power output decreased
both in absolute numbers and in comparison with the
The Journal of Thoracic and
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Table III. Number of days in circulation and cause of
death for the entire series of 10 dogs
Days in 
Dog No. circulation Cause of death
1 17 Bleeding from arterial pressure monitoring 
site
2 72 Electively sacrificed
3 11 Incompetent valves; clot in conduit
4 7 Retained muscle plug from left ventricle
5 214 Embolism to iliac bifurcation; no clot in 
SMV
6 249 Spontaneous retroperitoneal hematoma
7 228 Alive as of July 7, 1998
8 115 Incompetent valve at second measurement;
clot in SMV with embolism to iliac 
bifurcation
9 16 Postoperative infection
10 99 Renal failure with microemboli to kidneys;
no clot in SMV
Fig 5. Pressure tracings taken from 1 animal at the time of a low-output study after 78 days in circulation. The
pressure recording after 1 hour of continuous low cardiac output was induced by propranolol infusion. The tran-
sition from temporarily inhibiting the SMV “OFF” to contraction at 33 Hz, 1:1, is shown. At this setting, almost
the entire total systemic output is flowing through the SMV.
LV power output at the 1:1 ratio, although SMV power
output remained greater than or about equal to the
minute work generated by the unassisted left ventricle.
Discussion
This study demonstrates that SMVs in a LV apex to
aorta configuration can function effectively in the cir-
culation. Maintenance of significant power output was
confirmed in 1 animal at the 8-month follow-up. SMVs
significantly unloaded the left ventricle, resulting in
decreases in the LV peak pressure, LV end-diastolic
pressure, the LV tension-time index, and LV stroke and
minute work. During SMV contraction, flow was redi-
rected from the LV outflow tract across the aortic valve
through the SMV. Total systemic flow did not change
significantly. To determine whether the redistribution
of flow dynamics caused by the 50% constriction of the
aorta would compromise cerebral circulation during
SMV contraction, a flow probe was placed around the
carotid artery in 1 animal during a measurement ses-
sion. During SMV stimulation at 33 and 50 Hz, mean
carotid flow was 97.1% and 97.4% of control flow with
the SMV OFF.
In previous acute studies of SMVs, power output,
when measured with a mock circulation device, was
intermediate between the stroke work of the right and
left ventricles.9 In these previous studies, power output
of the SMVs was equivalent to that of the right ventri-
cle because of the slower SMV contraction rate but did
not approach that of the left ventricle. In the present
study, the SMVs were able to generate stroke work
varying from approximately one half that of the unas-
sisted left ventricle at a 33-Hz burst frequency stimula-
tion and a 1:2 contraction ratio, to nearly equal to the
unassisted LV at 50 Hz, 1:2. While pumping at only
one half the rate of the heart rate, the power output of
the SMVs was 36% and 45% of unassisted LVMW at
33 and 50 Hz. Power output of the SMVs stimulated at
a 1:2 contraction ratio with the heart was maintained
over time.
Because the SMVs were preloaded by LV contrac-
tion, our use of mean SMV pressure during ejection to
determine SMV SW without taking LV preloading into
consideration would likely overestimate SMV SW and
thereby SMV power output. At the same time, an
assumption that SMV relaxation plays no role in deter-
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Fig 6. Flow measured through the SMV and ascending aorta in 1 animal at several points over time. A, A depic-
tion of the flow with the SMV OFF. There is minimal passive flow through the SMV. B, A depiction of the flow
with the SMV contracting at 33 Hz, 1:2. From 78 days in circulation onward, the SMV flow is equal to the flow
across the aortic valve. Total blood flow, sum of aortic flow and SMV flow.
A B
mining preload and passive flow through the SMV dur-
ing assist may have underestimated SMV stroke vol-
ume and thereby underestimated SMV SW and power
output. Clearly, further studies are needed to determine
“true” stroke work of the SMV; a conductance catheter
and other methods to derive pressure-volume loops
from the SMV will help us more accurately determine
stroke work and power output.
Some earlier studies on the feasibility of skeletal
muscle for cardiac assist used a left ventricle–to–aorta
model. Stevens and colleagues10,11 performed acute
studies with an unconditioned rectus muscle and
demonstrated, before muscle fatigue occurred, skeletal-
muscle assist increased total cardiac output during b -
blockade–induced heart failure. Brister and cowork-
ers,12 in an acute study, used a similar model, but with
a single valve in the afferent position. The LV
apex–to–aorta connection has been evaluated in a com-
puter model by Platt and colleagues,13 who determined
it to be the most efficient form of ventricular assist.
In our previous attempts to establish the LV
apex–to–aorta configuration as a chronic model, we ini-
tially had early thrombosis of the SMV circuit.14 In this
previous study, flow through the SMV was dependent on
SMV contraction; with chronic stimulation at a 1:2 ratio
with the heart, stagnation of blood flow inside the SMV
secondary to the lower contraction rate may have
encouraged thrombus formation. To promote continuous
passive flow through the SMV, a constriction of the aorta
proximal to the SMV-aortic anastomosis was created.6
One dog in this previous series survived 76 days, being
killed at that time because of an infected indwelling flow
probe. The remaining 4 dogs lived only up to 2 weeks,
dying of rupture of the SMV or the aortic anastomosis
and erosion of a flow probe into the great vessels. We
were previously able to develop a chronic model of
SMV aortic counterpulsation with pericardium-lined
SMVs; pericardium-lined SMVs did not rupture and
appeared to exhibit thromboresistance.7 Therefore the
present study incorporated the use of autogenous peri-
cardium to line the SMVs and the presence of an aortic
constriction to create passive SMV flow.
We have used a propranolol infusion to simulate low
cardiac output in a previous study.7 In the previous
study, during profound low cardiac output, SMV func-
tion, measured as percent augmentation of diastolic
blood pressure, improved under heart failure conditions
when compared with control. The propranolol infusion
did not seem to significantly affect SMV performance.
Because of our past experience with this model of heart
failure, we used propranolol to simulate severe cardiac
dysfunction. In our past experience with this heart fail-
ure model, animals that underwent a propranolol study
at 2 weeks after the SMV was placed in circulation
experienced a high mortality.7 In fact, in this current
study, 1 animal’s infusion had to be terminated because
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Fig 7. Stroke work in the SMV, the native left ventricle (with the SMV OFF), and the left ventricle during SMV
contraction at 33 Hz, 1:2 (A) and 50 Hz, l:2 (B), measured in 1 animal over time. At 33 Hz, SMV SW was equiv-
alent to that of the native left ventricle. At 50 Hz, SMV SW generally exceed that of the native left ventricle. 
A B
of severe hypotension. For this study, only animals that
survived up to 3 months received a propranolol infu-
sion. Unfortunately, not all of the animals that survived
this long were measured during propranolol-induced
failure. There was a trend toward improvement of
blood flow through the SMV compared to total sys-
temic flow for 50 Hz, 1:2, and both 33 and 50 Hz at a
1:1 ratio. There was also an increase in the amount of
total systemic flow when compared between the SMV
ON at a 1:1 ratio and the SMV OFF. It is likely that
these trends did not achieve statistical significance
because of the small number of animals that underwent
a propranolol study. Future studies must further define
the potential for SMVs to provide assistance to a fail-
ing ventricle using this or other models of heart failure.
When examining the data over time, we noted
decreases in SMV performance during the first 2 weeks
after placement of the SMV into circulation. We have
noted similar decreases empirically in other studies.
Although electrical stimulation at 2 Hz has been shown
to change the fiber type, it is possible that the muscle
may not be fully adapted to perform chronically under
loaded conditions. However, after this 2-week period,
SMV flow returned toward baseline and remained sta-
ble thereafter in most dogs.
The aortic constriction was performed with the SMV
pumping at the chronic stimulation parameters of 33
Hz, 1:2 ratio. The constrictions were adjusted to cause
one third to one half of the total systemic flow to go
through the SMV when the cardiomyostimulator was
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Fig 8. Power output of SMV, native left ventricle (with SMV OFF) and left ventricle during SMV assist at 4 combi-
nations of burst frequency and contraction ratio for 1 animal over time. A, At a 1:2 ratio, SMV power output remained
relatively stable. B, Power output at the 1:1 ratio was available for only the initial and 2 latest measurements.
A B
programmed at the chronic settings. Because there are
2 potential outflow tracts from the left ventricle in this
model, the aortic constriction does not appreciably
increase afterload when compared with the normal
heart with a single LV outflow tract through the aortic
valve. The aortic constriction merely redistributes a
portion of blood through the alternative outflow tract to
help prevent SMV thrombus formation. In reviewing
the resulting passive SMV flow over time in circulation
for each animal plus each animal’s fate, no obvious
correlation was found between absolute amount of pas-
sive flow or percent passive flow of total systemic flow
and number of days in circulation with the presence or
absence of clot in the SMV. Further experiments may
help to determine what degree of aortic constriction, if
any, is necessary for this model. Additionally, it is
unknown when performed on an animal with a failing
heart, whether similar aortic constrictions will result in
a decreased incidence of SMV thrombi.
This study demonstrates conclusively that SMVs in
an LV apex–to–aorta configuration can effectively and
efficiently provide chronic cardiac assistance for up to
8 months in the circulation. Before SMVs in an LV
apex–to–aorta configuration can be considered for clin-
ical trials, further refinement is necessary to eliminate
the significant attrition that occurred during this study.
SMVs will also need to be tested in a chronic heart fail-
ure model. Once a reliable, low mortality model has
been achieved, clinical evaluation should proceed.
We thank Elaine Hockman, PhD, for her assistance with
statistical analysis, and Janet Schofding, LVT, Lee Andrus,
LVT, Cynthia Cameron, LVT, and Elizabeth Dawe, DVM, for
their care of the animals used in this experiment.
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Discussion
Dr Juan C. Chachques (Paris, France). I saw in your pic-
tures that you are still using direct nerve pacing. Do you have
any problems with direct nerve stimulation? We use intra-
muscular electrodes because we believe that direct nerve
stimulation can induce fibrosis and nerve injury. 
Do you have a histologic control of the pericardium that
you use inside this SMV, and what is the adaptation of the
pericardium to this new function? Is this pericardium fresh or
treated with glutaraldehyde? 
Do you plan to use this configuration for the right heart?
Perhaps for the first clinical use it would be interesting to test
your SMVs for right ventricular support.
Dr Baciewicz. First, regarding muscle stimulation as com-
pared with nerve stimulation, we have always used the nerve
stimulation to stimulate the latissimus dorsi and have not
had a problem. I really do not have any experience with a
myostimulator. 
Second, in terms of how we treat the pericardium, we sim-
ply harvest it from phrenic nerve to phrenic nerve, place it in
saline solution, and then place it around the mandrel. We do
not have any special treatment for it. 
Third, at this point we have not used this particular model
in a right ventricle situation. 
Mr John H. Kennedy (Cambridge, England). I compli-
ment you on your determination in carrying along with what
is basically often a fraught project. What was the effect on
baroreceptor activity in the presence of a 50% constriction of
the proximal thoracic aorta? Normally in a waveform, one
would see that in an elevation of diastole, which we were not
privileged to see in your slides, and, of course, that would be
dependent on the synchrony in terms of radians of the pump
versus the natural heart. 
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Dr Baciewicz. I did not have room on the slides to show
you the carotid flow tracing, but essentially it is no different
from the femoral tracing.
Mr John R. Pepper (London, England). Do you have any
evidence of thromboembolism inside the SMV? Did you do
autopsies on the animals and look particularly at the kidneys? 
Dr Baciewicz. In fact, there were several sudden deaths
within 1 month in the study; but essentially in all the animals
that survived long term, our problem was peripheral emboli.
Two of the animals died of iliac emboli and 1 of renal failure
from renal emboli. However, on all the autopsies, we did not
notice any clot or thrombus in the SMV itself. Of course,
there are a lot of places in this model where thrombus could
develop: we have indwelling SMV catheters; there is a rela-
tive constriction in the thoracic aorta, and the animals were
given only 85 mg of aspirin per day. But that has been our
downfall in terms of keeping the animal alive long term. 
Dr Thierry G. Mesana (Marseille, France). It is fascinat-
ing to see a real biologic implantable device. But to be bio-
logic means to have less thromboemboli. Do you think that
your valves inside your ventricle are really necessary to assist
the heart? What is the role of these valves in the thromboem-
boli that you saw?
Dr Baciewicz. We do think the valves are necessary. We
did have earlier models where the valve conduits that we used
had been sort of discards or had been on the shelf for multi-
ple years; there was a number of emboli and thrombi on some
of these valved conduits. We are now having the conduits
made specifically for us; we have not noted a problem with
this.
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